| pubmed-article:8582109 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0034705 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0027754 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0035096 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0027752 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0205161 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:8582109 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:8582109 | pubmed:issue | 6-7 | lld:pubmed |
| pubmed-article:8582109 | pubmed:dateCreated | 1996-3-19 | lld:pubmed |
| pubmed-article:8582109 | pubmed:abstractText | 1. The levels of the neurotrophic factor, nerve growth factor (NGF) in the mesenteric vascular bed of the spontaneously hypertensive rat (SHR) were greater than those in the corresponding vascular bed of normotensive Wistar-Kyoto rats (WKY). 2. Administration of angiotensin II (200 ng/kg per min, by minipump) for 2 weeks to juvenile WKY rats increased the levels of NGF in the mesenteric vasculature to those seen in untreated SHR. 3. Administration of the angiotensin II receptor antagonists losartan (30 mg/kg per day, p.o.) or PD144277 (10 mg/kg per day, p.o.) to juvenile SHR for 4 weeks reduced the levels of NGF such that they were indistinguishable from the values obtained for normotensive WKY rats. 4. The results confirm the elevated level of NGF in the mesenteric vasculature of the SHR and suggest that angiotensin II may play a role in regulating the abnormal concentrations of the protein in this tissue. | lld:pubmed |
| pubmed-article:8582109 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8582109 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8582109 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8582109 | pubmed:issn | 0305-1870 | lld:pubmed |
| pubmed-article:8582109 | pubmed:author | pubmed-author:FrewinD BDB | lld:pubmed |
| pubmed-article:8582109 | pubmed:author | pubmed-author:HeadR JRJ | lld:pubmed |
| pubmed-article:8582109 | pubmed:author | pubmed-author:TungC MCM | lld:pubmed |
| pubmed-article:8582109 | pubmed:author | pubmed-author:JeffresonSS | lld:pubmed |
| pubmed-article:8582109 | pubmed:author | pubmed-author:ZettlerCC | lld:pubmed |
| pubmed-article:8582109 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8582109 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:8582109 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8582109 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8582109 | pubmed:pagination | 478-80 | lld:pubmed |
| pubmed-article:8582109 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:meshHeading | pubmed-meshheading:8582109-... | lld:pubmed |
| pubmed-article:8582109 | pubmed:articleTitle | The influence of the renin angiotensin system on abnormal expression of nerve growth factor in the spontaneously hypertensive rat. | lld:pubmed |
| pubmed-article:8582109 | pubmed:affiliation | Department of Clinical and Experimental Pharmacology, University of Adelaide, South Australia. | lld:pubmed |
| pubmed-article:8582109 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8582109 | pubmed:publicationType | Comparative Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8582109 | lld:pubmed |
